Small wearable patches that continuously scan your blood and zap numbers to your smartphone are about to be everywhere.
Once the sole domain of people with diabetes, glucose monitors are gaining popularity as a health tracking accessory not that different from an Apple Watch or an Oura Ring. On Wednesday, the FDA approved a glucose monitoring system from the startup Signos for weight management – a first for the tech, which represents a growing corner of the digital wellness space.
“Everyone deserves access to insights that help them live healthier, longer, more vibrant lives,” Signos CEO Sharam Fouladgar-Mercer said in a press release. “Signos isn’t just about data; it’s about giving people ownership over their health and weight journeys in a way never before seen.”
Signos designed an